Private & confidential
Dr. Lin Yi
Chinese name: 林毅
National TCM Master, Chief TCM Physician, Professor, Doctoral Supervisor . Breast Diseases
Dr. Lin Yi is a National TCM Master and the founder of the breast disease specialty at Guangdong Provincial Hospital of Chinese Medicine. With nearly 60 years of practice, she created the inflammation-cancer differentiation theory for breast diseases and specializes in the integrative Chinese-Western treatment of breast cancer and inflammatory breast conditions.
60+
Years of Clinical Practice
14
In-Hospital TCM Preparations Developed
1200+
Citations of Her Chief-Edited Textbook
About Dr. Lin Yi
Dr. Lin Yi is a National TCM Master and the founder of the breast disease specialty at Guangdong Provincial Hospital of Chinese Medicine, a chief TCM physician, professor and lifetime professor of Guangzhou University of Chinese Medicine. With nearly 60 years of clinical practice, she created the inflammation-cancer differentiation theory for breast diseases and the six-stagnation approach to treating breast disorders. She specializes in the integrative Chinese-Western treatment of breast cancer and inflammatory breast diseases. She has published more than 100 papers and edited seven books, developed 15 pure Chinese herbal preparations, and obtained two national invention patents. Her innovative drug Jinrong Granules received a national new drug certificate in 2018.
1、National TCM Master (4th batch) and one of the first National Distinguished TCM Practitioners
2、Founder of the breast disease specialty at Guangdong Provincial Hospital of Chinese Medicine and lifetime professor of Guangzhou University of Chinese Medicine
3、Created the inflammation-cancer differentiation theory for breast diseases and the six-stagnation approach to treating breast disorders
4、Published more than 100 papers and 7 edited books, developed 15 pure herbal preparations and obtained 2 national invention patents
5、The innovative drug Jinrong Granules received a national new drug certificate in 2018
6、Won the Guangdong Provincial Science and Technology Progress Second Prize (2020) and the Ministry of Education Science and Technology Progress Second Prize (2019)
Dr. Lin Yi ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Breast cancer
She integrates Chinese and Western medicine to treat breast cancer and provides post-surgical conditioning; her inflammation-cancer differentiation theory and herbal formulas support patients through surgery, chemotherapy and radiotherapy, harmonizing essence qi and blood to address advanced breast cancer cachexia and aid recovery
Inflammatory breast diseases
She treats acute mastitis and plasma cell mastitis; as a leading expert she uses Chinese medicine to control breast inflammation, resolve masses and preserve the breast, applying the six-stagnation theory and syndrome differentiation to regulate qi and blood and reduce recurrence
Breast hyperplasia
Treatment is based on the six-stagnation theory; she addresses breast hyperplasia and related breast pain through syndrome differentiation, regulating qi, blood and emotion, and uses her developed herbal preparations and nearly sixty years of experience to relieve distension, nodules and discomfort
More: breast nodules——diffuse breast lumps; postpartum lactation disorders——mastitis and insufficient milk; TCM rehabilitation——recovery after breast tumor surgery and cachexia care
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. XIAOPI Formula for Breast Hyperplasia and Breast Cancer
XIAOPI formula is an approved Chinese herbal medicine used for decades against mammary hyperplasia. Researchers showed it suppresses M2 tumour-associated macrophage polarisation and CXCL1 secretion, inhibiting breast cancer stem cells and lung metastasis in mouse xenografts, offering a safe immunomodulatory option for women seeking traditional breast disease treatment in China.
Related link: https://pubmed.ncbi.nlm.nih.gov/31803057/
2. XIAOPI Formula Blocks Pre-Metastatic Niche in Breast Cancer
This study explored how XIAOPI formula prevents the pre-metastatic niche, a prerequisite for breast cancer spread. By reducing CXCL1 released from tumour-associated macrophages, it limited recruitment of bone-marrow progenitor cells and lung metastasis in advanced breast cancer models, supporting herbal breast cancer metastasis prevention for patients after mastectomy.
3. Network Pharmacology Validates CXCL1 Target of XIAOPI Formula
Using network pharmacology, investigators identified eighty-one genes linked to XIAOPI formula’s breast cancer chemoprevention and validated CXCL1 as the key target. Blocking CXCL1 reversed XIAOPI’s inhibition of breast cancer migration, invasion, epithelial-mesenchymal transition and mammosphere formation, giving molecular evidence for herbal breast cancer prevention.
Related link: https://pubmed.ncbi.nlm.nih.gov/29109519/
4. Cyclic Herbal Therapy for Atypical Breast Hyperplasia
Lin Yi’s breast disease centre reported cyclic herbal therapy for atypical mammary hyperplasia achieving a 91.8 percent effective rate, reducing breast nodules and pain. The regimen reflects his holistic endocrine-immunity approach, helping women with breast nodules avoid unnecessary surgery. An official Guangdong hospital feature documents the legacy of this celebrated breast specialist.
5. Jinrong Granule: First TCM Innovative Drug from a Hospital Formula
Jinrong Granule, derived from Lin Yi’s clinical formula, was approved in 2018 as a Class 1.1 innovative Chinese medicine for breast hyperplasia. One of China’s first hospital-formula-derived new drugs, it regulates endocrine and immune imbalance to relieve breast pain and shrink nodules, and later received national TCM secondary protection.
6. National TCM Master Lin Yi: Breast Disease Legacy
A feature profile of Lin Yi, China’s leading traditional Chinese medicine breast disease specialist and lifelong professor at Guangdong Provincial Hospital of Chinese Medicine. It documents his founding of the country’s first TCM breast clinic, his self-developed preparations and his role training breast specialists, useful for patients seeking an experienced breast disease practitioner.
Related link: http://jilu.china.com.cn/2025-06/04/content_43134987.htm
Where Dr. Lin Yi practices
Guangdong Provincial Hospital of Chinese Medicine
Chinese name: 广东省中医院
Guangdong Provincial Hospital of Chinese Medicine, founded in 1933 and known as the leading Chinese-medicine hospital in southern China, is China's largest tertiary TCM hospital with 3,524 beds and two grand masters, topping national TCM rankings for eight years.
Since 1933
93 years of TCM care
3,524
Licensed beds
6.84 million (2021)
Annual outpatient visits
9
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.
Ready to plan your consultation with Dr. Lin Yi?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Guangzhou University of Chinese Medicine English Profile: https://www.gzucm.edu.cn/en/info/1051/1066.htm
- Guangdong Provincial Hospital of Chinese Medicine Profile: https://www.gdhtcm.com/expert/show_100000333369275.html
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Lin Yi.